Human Pathology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Human Pathology is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,460 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1532-8392 · 0046-8177
Country
United States
Access
Not open access / not declared
Declared publication charge
3,460 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1971-01-01
Indexing
MEDLINE
APC
3,460 USD
Declared review time (DOAJ)
—
Actual review time (measured)
68 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

14941

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

231

i10-index

8915

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
78%
ORCID iDs in current deposits
65%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9421547
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
Show all subjects (50)
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Urologic and reproductive health conditions
  • Urologic and reproductive health conditions
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Renal and related cancers
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Renal and related cancers
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
  • Medical Imaging and Pathology Studies
  • Medical Imaging and Pathology Studies
  • Breast Cancer Treatment Studies
  • Urinary and Genital Oncology Studies
  • Urinary and Genital Oncology Studies
  • Breast Cancer Treatment Studies
  • Soft tissue tumor case studies
  • Soft tissue tumor case studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: